The FDA has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active Crohn disease.

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...

In patients with Crohn's disease and intermediate to high preoperative corticosteroid use, primary ileocaecal resection leads ...

It can occur with inflammatory bowel disease (IBD) or Crohn’s disease. You can take oral and topical corticosteroids ... but it may help alleviate symptoms. An ileum resection is a procedure ...

Crohn’s disease. An autoimmune condition in which ... The first and one of the most common symptoms of short bowel syndrome is diarrhea that doesn’t go away. In the early stages, you may ...

While Crohn's disease is often associated with digestive issues, some symptoms may seem unrelated ... Crohn’s disease patients develop skin or oral issues. Dr Borkar explains that Crohn's ...

Protagonist Therapeutics, Inc.'s VERIFY and ANTHEM-UC studies show breakthroughs in polycythemia vera and ulcerative colitis. Click fo rmy PTGX update.

In some cases, the medications you take for Crohn’s disease could cause symptoms in your eyes. Oral steroids frequently used to treat Crohn’s can cause eye problems, including glaucoma.

and those who had other symptoms, which we termed non-odonto-type disease," explains Rena Okawa, lead author of the study. "We were surprised to see big differences in oral manifestations between ...